MeiraGTx Announces the Upcoming Presentation of 15 Abstracts at the European Society of Gene and Cell Therapy (ESGCT) 2022 Annual Congress

October 4, 2022

https://www.globenewswire.com/news-release/2022/10/04/2527718/0/en/MeiraGTx-Announces-the-Upcoming-Presentation-of-15-Abstracts-at-the-European-Society-of-Gene-and-Cell-Therapy-ESGCT-2022-Annual-Congress.html

LONDON and NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company will exhibit 15 poster presentations at the European Society of Gene and Cell Therapy (ESGCT) 2022 Annual Congress, which will be held from October 11-14, 2022, in Edinburgh, Scotland.

Read more at globenewswire.com

Related news for (MGTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.